ESC Premium Access

Duration of DAPT should be beyond 1 year post acute coronary syndrome - CON.

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Presentation

About the speaker

Associate Professor Giuseppe De Luca

University of Eastern Piedmont, Novara (Italy)
1 presentation
0 follower

5 more presentations in this session

P2Y12 inhibition should be started at the time of NSTEMI diagnosis - PRO.

Speaker: Professor M. Valgimigli (Lugano, CH)

Thumbnail

P2Y12 inhibition should be started at the time of NSTEMI diagnosis - CON.

Speaker: Professor G. Montalescot (Paris, FR)

Thumbnail

P2Y12 inhibition should be started at the time of NSTEMI diagnosis -Discussion

Thumbnail

Duration of DAPT should be beyond 1 year post acute coronary syndrome - PRO.

Speaker: Doctor M. Bonaca (Aurora, US)

Thumbnail

Duration of DAPT should be beyond 1 year post acute coronary syndrome - Discussion

Thumbnail

Access the full session

Controversies in anti-platelet therapy

Speakers: Associate Professor G. De Luca, Professor M. Valgimigli, Professor G. Montalescot, Doctor M. Bonaca
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

Open Access

Antithrombotic therapy post-PCI: insights from Europe and North America.

28 August 2021

ESC Premium Access

Management of endocarditis: state of the art

28 August 2021

ESC Premium Access

Postcovid myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19

27 August 2021

This platform is supported by

logo Novo Nordisk